The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2008, 181, 3202 -3211
Copyright © 2008 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kawamura, K.
Right arrow Articles by Forsthuber, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kawamura, K.
Right arrow Articles by Forsthuber, T. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene

Myelin-Reactive Type B T Cells and T Cells Specific for Low-Affinity MHC-Binding Myelin Peptides Escape Tolerance in HLA-DR Transgenic Mice1

Kazuyuki Kawamura*, Katherine A. McLaughlin{dagger}, Robert Weissert{ddagger} and Thomas G. Forsthuber2,*

* Department of Biology, University of Texas at San Antonio, San Antonio, TX 78249; {dagger} Harvard University and Dana-Farber Cancer Institute, Boston, MA 02115; and {ddagger} Hertie Institute for Clinical Brain Research, Department of General Neurology, University of Tübingen, Tübingen, Germany

Genes of the MHC show the strongest genetic association with multiple sclerosis (MS), but the underlying mechanisms have remained unresolved. In this study, we asked whether the MS-associated MHC class II molecules, HLA-DRB1*1501, HLA-DRB5*0101, and HLA-DRB1*0401, contribute to autoimmune CNS demyelination by promoting pathogenic T cell responses to human myelin basic protein (hMBP), using three transgenic (Tg) mouse lines expressing these MHC molecules. Unexpectedly, profound T cell tolerance to the high-affinity MHC-binding hMBP82-100 epitope was observed in all Tg mouse lines. T cell tolerance to hMBP82-100 was abolished upon back-crossing the HLA-DR Tg mice to MBP-deficient mice. In contrast, T cell tolerance was incomplete for low-affinity MHC-binding hMBP epitopes. Furthermore, hMBP82-100-specific type B T cells escaped tolerance in HLA-DRB5*0101 Tg mice. Importantly, T cells specific for low-affinity MHC-binding hMBP epitopes and hMBP82-100-specific type B T cells were highly encephalitogenic. Collectively, the results show that MS-associated MHC class II molecules are highly efficient at inducing T cell tolerance to high-affinity MHC-binding epitope, whereas autoreactive T cells specific for the low-affinity MHC-binding epitopes and type B T cells can escape the induction of T cell tolerance and may promote MS.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by Grant NS-428846 from the National Institutes of Health, and Grants RG3499 and RG3701 from the National Multiple Sclerosis Society (to T.G.F.). K.K. is recipient of a Postdoctoral Fellowship from the National Multiple Sclerosis Society.

2 Address correspondence and reprint requests to Dr. Thomas G. Forsthuber, Department of Biology, University of Texas at San Antonio, One UTSA Circle, San Antonio, TX 78249. E-mail address: thomas.forsthuber{at}utsa.edu

3 Abbreviations used in this paper: MS, multiple sclerosis; MBP, myelin basic protein; EAE, experimental autoimmune encephalomyelitis; h, human; m, murine; Tg, transgenic; BCL, B cell line; LN, lymph node; TCL, T cell line; TCC, T cell clone; AEP, asparagine endopeptidase.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2008 by The American Association of Immunologists, Inc. All rights reserved.